Migdal Insurance & Financial Holdings’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-471
| Closed | -$34K | – | 370 |
|
|
2025
Q1 | $34K | Buy |
471
+61
| +15% | +$4.4K | ﹤0.01% | 314 |
|
|
2024
Q4 | $30K | Buy |
+410
| New | +$30K | ﹤0.01% | 253 |
|
|
2024
Q3 | – | Sell |
-76
| Closed | -$7K | – | 455 |
|
|
2024
Q2 | $7K | Buy |
+76
| New | +$7K | ﹤0.01% | 443 |
|
|
2020
Q4 | – | Sell |
-13,193
| Closed | -$1.05M | – | 676 |
|
|
2020
Q3 | $1.05M | Sell |
13,193
-11,432
| -46% | -$912K | 0.01% | 280 |
|
|
2020
Q2 | $1.7M | Buy |
24,625
+8,032
| +48% | +$555K | 0.03% | 202 |
|
|
2020
Q1 | $1.04M | Sell |
16,593
-4,113
| -20% | -$259K | 0.02% | 171 |
|
|
2019
Q4 | $1.61M | Buy |
20,706
+2,316
| +13% | +$180K | 0.03% | 158 |
|
|
2019
Q3 | $1.35M | Buy |
18,390
+6,837
| +59% | +$501K | 0.03% | 210 |
|
|
2019
Q2 | $711K | Buy |
11,553
+3,351
| +41% | +$206K | 0.02% | 284 |
|
|
2019
Q1 | $523K | Buy |
8,202
+3,966
| +94% | +$253K | 0.01% | 292 |
|
|
2018
Q4 | $216K | Sell |
4,236
-246
| -5% | -$12.5K | ﹤0.01% | 368 |
|
|
2018
Q3 | $260K | Buy |
4,482
+2,640
| +143% | +$153K | 0.01% | 485 |
|
|
2018
Q2 | $89K | Buy |
1,842
+1,785
| +3,132% | +$86.2K | ﹤0.01% | 527 |
|
|
2018
Q1 | $3K | Buy |
+57
| New | +$3K | ﹤0.01% | 590 |
|